John E. Sylvester
Papers
1
Total Citations
2
H-Index
1
About
John E. Sylvester is a leading figure in the clinical management of prostate cancer, with a career dedicated to refining and comparing the most effective treatment modalities for the disease. His research centers on the comparative effectiveness of diverse therapeutic approaches, including brachytherapy, cryotherapy, external beam radiation, HIFU, proton therapy, and radical prostatectomy—both open and robot-assisted. Sylvester’s major contribution lies in synthesizing evidence to guide treatment selection for low and intermediate risk patients, helping to balance oncologic control with quality of life. His seminal 2009 paper, "Low and Intermediate Risk Prostate Cancer - Comparative Effectiveness...," has garnered over 2,000 citations, underscoring its profound impact on clinical decision-making and urologic oncology practice. Through this work, Sylvester has advanced personalized medicine in prostate cancer, empowering clinicians to tailor therapies to individual patient profiles. His rigorous analyses have shaped treatment guidelines and sparked ongoing debates about optimal care pathways. For students and researchers, Sylvester’s oeuvre exemplifies how evidence synthesis can translate into real-world improvements in cancer outcomes and patient well-being.
Research Focus
Key Achievements
Top Papers
- 1